Circulating	O
CXCR5	B:C0300729
+	O
PD	O
-	I:C0135710
1	I:C0135710
+	O
ICOS	O
+	O
Follicular	O
T	O
Helper	I:C0018894
Cells	I:C0018894
Are	O
Increased	O
Close	O
to	O
the	O
Diagnosis	O
of	O
Type	O
1	I:C0011854
Diabetes	I:C0011854
in	O
Children	O
With	O
Multiple	O
Autoantibodies	I:C1855872
.	O

Circulating	O
CXCR5	O
+	O
PD	B:C0135710
-	I:C0135710
1	I:C0135710
+	O
ICOS	O
+	O
Follicular	O
T	O
Helper	I:C0018894
Cells	I:C0018894
Are	O
Increased	O
Close	O
to	O
the	O
Diagnosis	O
of	O
Type	O
1	I:C0011854
Diabetes	I:C0011854
in	O
Children	O
With	O
Multiple	O
Autoantibodies	I:C1855872
.	O

Circulating	O
CXCR5	O
+	O
PD	O
-	I:C0135710
1	I:C0135710
+	O
ICOS	B:C1570399
+	O
Follicular	O
T	O
Helper	I:C0018894
Cells	I:C0018894
Are	O
Increased	O
Close	O
to	O
the	O
Diagnosis	O
of	O
Type	O
1	I:C0011854
Diabetes	I:C0011854
in	O
Children	O
With	O
Multiple	O
Autoantibodies	I:C1855872
.	O

Circulating	O
CXCR5	O
+	O
PD	O
-	I:C0135710
1	I:C0135710
+	O
ICOS	O
+	O
Follicular	B:C1571705
T	O
Helper	I:C0018894
Cells	I:C0018894
Are	O
Increased	O
Close	O
to	O
the	O
Diagnosis	O
of	O
Type	O
1	I:C0011854
Diabetes	I:C0011854
in	O
Children	O
With	O
Multiple	O
Autoantibodies	I:C1855872
.	O

Circulating	O
CXCR5	O
+	O
PD	O
-	I:C0135710
1	I:C0135710
+	O
ICOS	O
+	O
Follicular	O
T	B:C0018894
Helper	I:C0018894
Cells	I:C0018894
Are	O
Increased	O
Close	O
to	O
the	O
Diagnosis	O
of	O
Type	O
1	I:C0011854
Diabetes	I:C0011854
in	O
Children	O
With	O
Multiple	O
Autoantibodies	I:C1855872
.	O

Circulating	O
CXCR5	O
+	O
PD	O
-	I:C0135710
1	I:C0135710
+	O
ICOS	O
+	O
Follicular	O
T	O
Helper	I:C0018894
Cells	I:C0018894
Are	O
Increased	O
Close	O
to	O
the	O
Diagnosis	B:C1704656
of	O
Type	O
1	I:C0011854
Diabetes	I:C0011854
in	O
Children	O
With	O
Multiple	O
Autoantibodies	I:C1855872
.	O

Circulating	O
CXCR5	O
+	O
PD	O
-	I:C0135710
1	I:C0135710
+	O
ICOS	O
+	O
Follicular	O
T	O
Helper	I:C0018894
Cells	I:C0018894
Are	O
Increased	O
Close	O
to	O
the	O
Diagnosis	O
of	O
Type	B:C0011854
1	I:C0011854
Diabetes	I:C0011854
in	O
Children	O
With	O
Multiple	O
Autoantibodies	I:C1855872
.	O

Circulating	O
CXCR5	O
+	O
PD	O
-	I:C0135710
1	I:C0135710
+	O
ICOS	O
+	O
Follicular	O
T	O
Helper	I:C0018894
Cells	I:C0018894
Are	O
Increased	O
Close	O
to	O
the	O
Diagnosis	O
of	O
Type	O
1	I:C0011854
Diabetes	I:C0011854
in	O
Children	O
With	O
Multiple	B:C1855872
Autoantibodies	I:C1855872
.	O

Although	O
type	B:C0011854
1	I:C0011854
diabetes	I:C0011854
(	O
type	O
1	I:C0011854
diabetes	I:C0011854
)	O
is	O
primarily	O
perceived	O
as	O
a	O
T	O
cell	I:C0039194
-	O
driven	O
autoimmune	O
disease	I:C0004364
,	O
islet	O
autoantibodies	O
are	O
the	O
best	O
currently	O
available	O
biomarker	O
for	O
autoimmunity	O
and	O
disease	O
risk	I:C1281905
.	O

Although	O
type	O
1	I:C0011854
diabetes	I:C0011854
(	O
type	B:C0011854
1	I:C0011854
diabetes	I:C0011854
)	O
is	O
primarily	O
perceived	O
as	O
a	O
T	O
cell	I:C0039194
-	O
driven	O
autoimmune	O
disease	I:C0004364
,	O
islet	O
autoantibodies	O
are	O
the	O
best	O
currently	O
available	O
biomarker	O
for	O
autoimmunity	O
and	O
disease	O
risk	I:C1281905
.	O

Although	O
type	O
1	I:C0011854
diabetes	I:C0011854
(	O
type	O
1	I:C0011854
diabetes	I:C0011854
)	O
is	O
primarily	O
perceived	O
as	O
a	O
T	B:C0039194
cell	I:C0039194
-	O
driven	O
autoimmune	O
disease	I:C0004364
,	O
islet	O
autoantibodies	O
are	O
the	O
best	O
currently	O
available	O
biomarker	O
for	O
autoimmunity	O
and	O
disease	O
risk	I:C1281905
.	O

Although	O
type	O
1	I:C0011854
diabetes	I:C0011854
(	O
type	O
1	I:C0011854
diabetes	I:C0011854
)	O
is	O
primarily	O
perceived	O
as	O
a	O
T	O
cell	I:C0039194
-	O
driven	O
autoimmune	B:C0004364
disease	I:C0004364
,	O
islet	O
autoantibodies	O
are	O
the	O
best	O
currently	O
available	O
biomarker	O
for	O
autoimmunity	O
and	O
disease	O
risk	I:C1281905
.	O

Although	O
type	O
1	I:C0011854
diabetes	I:C0011854
(	O
type	O
1	I:C0011854
diabetes	I:C0011854
)	O
is	O
primarily	O
perceived	O
as	O
a	O
T	O
cell	I:C0039194
-	O
driven	O
autoimmune	O
disease	I:C0004364
,	O
islet	B:C1522529
autoantibodies	O
are	O
the	O
best	O
currently	O
available	O
biomarker	O
for	O
autoimmunity	O
and	O
disease	O
risk	I:C1281905
.	O

Although	O
type	O
1	I:C0011854
diabetes	I:C0011854
(	O
type	O
1	I:C0011854
diabetes	I:C0011854
)	O
is	O
primarily	O
perceived	O
as	O
a	O
T	O
cell	I:C0039194
-	O
driven	O
autoimmune	O
disease	I:C0004364
,	O
islet	O
autoantibodies	B:C0004358
are	O
the	O
best	O
currently	O
available	O
biomarker	O
for	O
autoimmunity	O
and	O
disease	O
risk	I:C1281905
.	O

Although	O
type	O
1	I:C0011854
diabetes	I:C0011854
(	O
type	O
1	I:C0011854
diabetes	I:C0011854
)	O
is	O
primarily	O
perceived	O
as	O
a	O
T	O
cell	I:C0039194
-	O
driven	O
autoimmune	O
disease	I:C0004364
,	O
islet	O
autoantibodies	O
are	O
the	O
best	O
currently	O
available	O
biomarker	B:C0005516
for	O
autoimmunity	O
and	O
disease	O
risk	I:C1281905
.	O

Although	O
type	O
1	I:C0011854
diabetes	I:C0011854
(	O
type	O
1	I:C0011854
diabetes	I:C0011854
)	O
is	O
primarily	O
perceived	O
as	O
a	O
T	O
cell	I:C0039194
-	O
driven	O
autoimmune	O
disease	I:C0004364
,	O
islet	O
autoantibodies	O
are	O
the	O
best	O
currently	O
available	O
biomarker	O
for	O
autoimmunity	B:C0004368
and	O
disease	O
risk	I:C1281905
.	O

Although	O
type	O
1	I:C0011854
diabetes	I:C0011854
(	O
type	O
1	I:C0011854
diabetes	I:C0011854
)	O
is	O
primarily	O
perceived	O
as	O
a	O
T	O
cell	I:C0039194
-	O
driven	O
autoimmune	O
disease	I:C0004364
,	O
islet	O
autoantibodies	O
are	O
the	O
best	O
currently	O
available	O
biomarker	O
for	O
autoimmunity	O
and	O
disease	B:C1281905
risk	I:C1281905
.	O

These	O
antibodies	B:C0003241
are	O
produced	O
by	O
autoreactive	O
B	O
cells	I:C0004561
,	O
the	O
activation	O
of	O
which	O
is	O
largely	O
dependent	O
on	O
the	O
function	O
of	O
CD4	O
(+	O
)	O
CXCR5	O
(+	O
)	O
follicular	O
T	O
helper	I:C0018894
cells	I:C0018894
(	O
Tfh	O
)	O
.	O

These	O
antibodies	O
are	O
produced	O
by	O
autoreactive	O
B	B:C0004561
cells	I:C0004561
,	O
the	O
activation	O
of	O
which	O
is	O
largely	O
dependent	O
on	O
the	O
function	O
of	O
CD4	O
(+	O
)	O
CXCR5	O
(+	O
)	O
follicular	O
T	O
helper	I:C0018894
cells	I:C0018894
(	O
Tfh	O
)	O
.	O

These	O
antibodies	O
are	O
produced	O
by	O
autoreactive	O
B	O
cells	I:C0004561
,	O
the	O
activation	B:C2259068
of	O
which	O
is	O
largely	O
dependent	O
on	O
the	O
function	O
of	O
CD4	O
(+	O
)	O
CXCR5	O
(+	O
)	O
follicular	O
T	O
helper	I:C0018894
cells	I:C0018894
(	O
Tfh	O
)	O
.	O

These	O
antibodies	O
are	O
produced	O
by	O
autoreactive	O
B	O
cells	I:C0004561
,	O
the	O
activation	O
of	O
which	O
is	O
largely	O
dependent	O
on	O
the	O
function	O
of	O
CD4	B:C0003323
(+	O
)	O
CXCR5	O
(+	O
)	O
follicular	O
T	O
helper	I:C0018894
cells	I:C0018894
(	O
Tfh	O
)	O
.	O

These	O
antibodies	O
are	O
produced	O
by	O
autoreactive	O
B	O
cells	I:C0004561
,	O
the	O
activation	O
of	O
which	O
is	O
largely	O
dependent	O
on	O
the	O
function	O
of	O
CD4	O
(+	O
)	O
CXCR5	B:C0300729
(+	O
)	O
follicular	O
T	O
helper	I:C0018894
cells	I:C0018894
(	O
Tfh	O
)	O
.	O

These	O
antibodies	O
are	O
produced	O
by	O
autoreactive	O
B	O
cells	I:C0004561
,	O
the	O
activation	O
of	O
which	O
is	O
largely	O
dependent	O
on	O
the	O
function	O
of	O
CD4	O
(+	O
)	O
CXCR5	O
(+	O
)	O
follicular	B:C1571705
T	O
helper	I:C0018894
cells	I:C0018894
(	O
Tfh	O
)	O
.	O

These	O
antibodies	O
are	O
produced	O
by	O
autoreactive	O
B	O
cells	I:C0004561
,	O
the	O
activation	O
of	O
which	O
is	O
largely	O
dependent	O
on	O
the	O
function	O
of	O
CD4	O
(+	O
)	O
CXCR5	O
(+	O
)	O
follicular	O
T	B:C0018894
helper	I:C0018894
cells	I:C0018894
(	O
Tfh	O
)	O
.	O

These	O
antibodies	O
are	O
produced	O
by	O
autoreactive	O
B	O
cells	I:C0004561
,	O
the	O
activation	O
of	O
which	O
is	O
largely	O
dependent	O
on	O
the	O
function	O
of	O
CD4	O
(+	O
)	O
CXCR5	O
(+	O
)	O
follicular	O
T	O
helper	I:C0018894
cells	I:C0018894
(	O
Tfh	B:C0018894
)	O
.	O

In	O
this	O
study	B:C2603343
,	O
we	O
have	O
comprehensively	O
characterized	O
the	O
Tfh	O
-	O
as	O
well	O
as	O
B	O
-	I:C0004561
cell	I:C0004561
compartments	O
in	O
a	O
large	O
cohort	O
of	O
children	O
with	O
newly	O
diagnosed	O
type	O
1	I:C0011854
diabetes	I:C0011854
or	O
at	O
different	O
stages	O
of	O
preclinical	O
type	O
1	I:C0011854
diabetes	I:C0011854
.	O

In	O
this	O
study	O
,	O
we	O
have	O
comprehensively	O
characterized	O
the	O
Tfh	B:C0018894
-	O
as	O
well	O
as	O
B	O
-	I:C0004561
cell	I:C0004561
compartments	O
in	O
a	O
large	O
cohort	O
of	O
children	O
with	O
newly	O
diagnosed	O
type	O
1	I:C0011854
diabetes	I:C0011854
or	O
at	O
different	O
stages	O
of	O
preclinical	O
type	O
1	I:C0011854
diabetes	I:C0011854
.	O

In	O
this	O
study	O
,	O
we	O
have	O
comprehensively	O
characterized	O
the	O
Tfh	O
-	O
as	O
well	O
as	O
B	B:C0004561
-	I:C0004561
cell	I:C0004561
compartments	O
in	O
a	O
large	O
cohort	O
of	O
children	O
with	O
newly	O
diagnosed	O
type	O
1	I:C0011854
diabetes	I:C0011854
or	O
at	O
different	O
stages	O
of	O
preclinical	O
type	O
1	I:C0011854
diabetes	I:C0011854
.	O

In	O
this	O
study	O
,	O
we	O
have	O
comprehensively	O
characterized	O
the	O
Tfh	O
-	O
as	O
well	O
as	O
B	O
-	I:C0004561
cell	I:C0004561
compartments	B:C2349967
in	O
a	O
large	O
cohort	O
of	O
children	O
with	O
newly	O
diagnosed	O
type	O
1	I:C0011854
diabetes	I:C0011854
or	O
at	O
different	O
stages	O
of	O
preclinical	O
type	O
1	I:C0011854
diabetes	I:C0011854
.	O

In	O
this	O
study	O
,	O
we	O
have	O
comprehensively	O
characterized	O
the	O
Tfh	O
-	O
as	O
well	O
as	O
B	O
-	I:C0004561
cell	I:C0004561
compartments	O
in	O
a	O
large	O
cohort	B:C0599755
of	O
children	O
with	O
newly	O
diagnosed	O
type	O
1	I:C0011854
diabetes	I:C0011854
or	O
at	O
different	O
stages	O
of	O
preclinical	O
type	O
1	I:C0011854
diabetes	I:C0011854
.	O

In	O
this	O
study	O
,	O
we	O
have	O
comprehensively	O
characterized	O
the	O
Tfh	O
-	O
as	O
well	O
as	O
B	O
-	I:C0004561
cell	I:C0004561
compartments	O
in	O
a	O
large	O
cohort	O
of	O
children	O
with	O
newly	O
diagnosed	B:C0011900
type	O
1	I:C0011854
diabetes	I:C0011854
or	O
at	O
different	O
stages	O
of	O
preclinical	O
type	O
1	I:C0011854
diabetes	I:C0011854
.	O

In	O
this	O
study	O
,	O
we	O
have	O
comprehensively	O
characterized	O
the	O
Tfh	O
-	O
as	O
well	O
as	O
B	O
-	I:C0004561
cell	I:C0004561
compartments	O
in	O
a	O
large	O
cohort	O
of	O
children	O
with	O
newly	O
diagnosed	O
type	B:C0011854
1	I:C0011854
diabetes	I:C0011854
or	O
at	O
different	O
stages	O
of	O
preclinical	O
type	O
1	I:C0011854
diabetes	I:C0011854
.	O

In	O
this	O
study	O
,	O
we	O
have	O
comprehensively	O
characterized	O
the	O
Tfh	O
-	O
as	O
well	O
as	O
B	O
-	I:C0004561
cell	I:C0004561
compartments	O
in	O
a	O
large	O
cohort	O
of	O
children	O
with	O
newly	O
diagnosed	O
type	O
1	I:C0011854
diabetes	I:C0011854
or	O
at	O
different	O
stages	O
of	O
preclinical	O
type	B:C0011854
1	I:C0011854
diabetes	I:C0011854
.	O

We	O
demonstrate	O
that	O
the	O
frequency	O
of	O
CXCR5	B:C0300729
(+	O
)	O
PD	O
-	I:C0135710
1	I:C0135710
(+	O
)	O
ICOS	O
(+	O
)	O
-	O
activated	O
circulating	O

We	O
demonstrate	O
that	O
the	O
frequency	O
of	O
CXCR5	O
(+	O
)	O
PD	B:C0135710
-	I:C0135710
1	I:C0135710
(+	O
)	O
ICOS	O
(+	O
)	O
-	O
activated	O
circulating	O

We	O
demonstrate	O
that	O
the	O
frequency	O
of	O
CXCR5	O
(+	O
)	O
PD	O
-	I:C0135710
1	I:C0135710
(+	O
)	O
ICOS	B:C1570399
(+	O
)	O
-	O
activated	O
circulating	O

We	O
demonstrate	O
that	O
the	O
frequency	O
of	O
CXCR5	O
(+	O
)	O
PD	O
-	I:C0135710
1	I:C0135710
(+	O
)	O
ICOS	O
(+	O
)	O
-	O
activated	B:C1867034
circulating	O

Tfh	B:C0018894
cells	I:C0018894
is	O
increased	O
both	O
in	O
children	O
with	O
newly	O
diagnosed	O
type	O
1	I:C0011854
diabetes	I:C0011854
and	O
in	O
autoantibody	O
-	O
positive	O
at	O
-	O
risk	O
children	O
with	O
impaired	O
glucose	O
tolerance	O
.	O

Tfh	O
cells	I:C0018894
is	O
increased	O
both	O
in	O
children	O
with	O
newly	O
diagnosed	B:C0011900
type	O
1	I:C0011854
diabetes	I:C0011854
and	O
in	O
autoantibody	O
-	O
positive	O
at	O
-	O
risk	O
children	O
with	O
impaired	O
glucose	O
tolerance	O
.	O

Tfh	O
cells	I:C0018894
is	O
increased	O
both	O
in	O
children	O
with	O
newly	O
diagnosed	O
type	B:C0011854
1	I:C0011854
diabetes	I:C0011854
and	O
in	O
autoantibody	O
-	O
positive	O
at	O
-	O
risk	O
children	O
with	O
impaired	O
glucose	O
tolerance	O
.	O

Tfh	O
cells	I:C0018894
is	O
increased	O
both	O
in	O
children	O
with	O
newly	O
diagnosed	O
type	O
1	I:C0011854
diabetes	I:C0011854
and	O
in	O
autoantibody	B:C0004358
-	O
positive	O
at	O
-	O
risk	O
children	O
with	O
impaired	O
glucose	O
tolerance	O
.	O

Interestingly	O
,	O
this	O
increase	O
was	O
only	O
evident	O
in	O
children	O
positive	O
for	O
two	O
or	O
more	O
biochemical	O
autoantibodies	B:C0004358
.	O

No	O
alterations	O
in	O
the	O
circulating	O
B	B:C0004561
-	I:C0004561
cell	I:C0004561
compartment	O
were	O
observed	O
in	O
children	O
with	O
either	O
prediabetes	O
or	O
diabetes	O
.	O

No	O
alterations	O
in	O
the	O
circulating	O
B	O
-	I:C0004561
cell	I:C0004561
compartment	B:C2349967
were	O
observed	O
in	O
children	O
with	O
either	O
prediabetes	O
or	O
diabetes	O
.	O

No	O
alterations	O
in	O
the	O
circulating	O
B	O
-	I:C0004561
cell	I:C0004561
compartment	O
were	O
observed	O
in	O
children	O
with	O
either	O
prediabetes	B:C0362046
or	O
diabetes	O
.	O

No	O
alterations	O
in	O
the	O
circulating	O
B	O
-	I:C0004561
cell	I:C0004561
compartment	O
were	O
observed	O
in	O
children	O
with	O
either	O
prediabetes	O
or	O
diabetes	B:C0011847
.	O

Our	O
results	O
demonstrate	O
that	O
Tfh	B:C0018894
activation	O
is	O
detectable	O
in	O
the	O
peripheral	O
blood	I:C0229664
close	O
to	O
the	O
presentation	O
of	O
clinical	O
type	O
1	I:C0011854
diabetes	I:C0011854
but	O
only	O
in	O
a	O
subgroup	O
of	O
children	O
identifiable	O
by	O
positivity	O
for	O
multiple	O
autoantibodies	I:C1855872
.	O

Our	O
results	O
demonstrate	O
that	O
Tfh	O
activation	O
is	O
detectable	B:C3830527
in	O
the	O
peripheral	O
blood	I:C0229664
close	O
to	O
the	O
presentation	O
of	O
clinical	O
type	O
1	I:C0011854
diabetes	I:C0011854
but	O
only	O
in	O
a	O
subgroup	O
of	O
children	O
identifiable	O
by	O
positivity	O
for	O
multiple	O
autoantibodies	I:C1855872
.	O

Our	O
results	O
demonstrate	O
that	O
Tfh	O
activation	O
is	O
detectable	O
in	O
the	O
peripheral	B:C0229664
blood	I:C0229664
close	O
to	O
the	O
presentation	O
of	O
clinical	O
type	O
1	I:C0011854
diabetes	I:C0011854
but	O
only	O
in	O
a	O
subgroup	O
of	O
children	O
identifiable	O
by	O
positivity	O
for	O
multiple	O
autoantibodies	I:C1855872
.	O

Our	O
results	O
demonstrate	O
that	O
Tfh	O
activation	O
is	O
detectable	O
in	O
the	O
peripheral	O
blood	I:C0229664
close	O
to	O
the	O
presentation	O
of	O
clinical	O
type	B:C0011854
1	I:C0011854
diabetes	I:C0011854
but	O
only	O
in	O
a	O
subgroup	O
of	O
children	O
identifiable	O
by	O
positivity	O
for	O
multiple	O
autoantibodies	I:C1855872
.	O

Our	O
results	O
demonstrate	O
that	O
Tfh	O
activation	O
is	O
detectable	O
in	O
the	O
peripheral	O
blood	I:C0229664
close	O
to	O
the	O
presentation	O
of	O
clinical	O
type	O
1	I:C0011854
diabetes	I:C0011854
but	O
only	O
in	O
a	O
subgroup	O
of	O
children	O
identifiable	O
by	O
positivity	O
for	O
multiple	B:C1855872
autoantibodies	I:C1855872
.	O

These	O
findings	B:C0243095
suggest	O
a	O
role	O
for	O
Tfh	O
cells	I:C0018894
in	O
the	O
pathogenesis	O
of	O
human	O
type	O
1	I:C0011854
diabetes	I:C0011854
and	O
carry	O
important	O
implications	O
for	O
targeting	O
Tfh	O
cells	I:C0018894
and	O
/	O
or	O
B	O
cells	I:C0004561
therapeutically	O
.	O

These	O
findings	O
suggest	O
a	O
role	O
for	O
Tfh	B:C0018894
cells	I:C0018894
in	O
the	O
pathogenesis	O
of	O
human	O
type	O
1	I:C0011854
diabetes	I:C0011854
and	O
carry	O
important	O
implications	O
for	O
targeting	O
Tfh	O
cells	I:C0018894
and	O
/	O
or	O
B	O
cells	I:C0004561
therapeutically	O
.	O

These	O
findings	O
suggest	O
a	O
role	O
for	O
Tfh	O
cells	I:C0018894
in	O
the	O
pathogenesis	B:C0699748
of	O
human	O
type	O
1	I:C0011854
diabetes	I:C0011854
and	O
carry	O
important	O
implications	O
for	O
targeting	O
Tfh	O
cells	I:C0018894
and	O
/	O
or	O
B	O
cells	I:C0004561
therapeutically	O
.	O

These	O
findings	O
suggest	O
a	O
role	O
for	O
Tfh	O
cells	I:C0018894
in	O
the	O
pathogenesis	O
of	O
human	B:C0086418
type	O
1	I:C0011854
diabetes	I:C0011854
and	O
carry	O
important	O
implications	O
for	O
targeting	O
Tfh	O
cells	I:C0018894
and	O
/	O
or	O
B	O
cells	I:C0004561
therapeutically	O
.	O

These	O
findings	O
suggest	O
a	O
role	O
for	O
Tfh	O
cells	I:C0018894
in	O
the	O
pathogenesis	O
of	O
human	O
type	B:C0011854
1	I:C0011854
diabetes	I:C0011854
and	O
carry	O
important	O
implications	O
for	O
targeting	O
Tfh	O
cells	I:C0018894
and	O
/	O
or	O
B	O
cells	I:C0004561
therapeutically	O
.	O

These	O
findings	O
suggest	O
a	O
role	O
for	O
Tfh	O
cells	I:C0018894
in	O
the	O
pathogenesis	O
of	O
human	O
type	O
1	I:C0011854
diabetes	I:C0011854
and	O
carry	O
important	O
implications	O
for	O
targeting	B:C0599894
Tfh	O
cells	I:C0018894
and	O
/	O
or	O
B	O
cells	I:C0004561
therapeutically	O
.	O

These	O
findings	O
suggest	O
a	O
role	O
for	O
Tfh	O
cells	I:C0018894
in	O
the	O
pathogenesis	O
of	O
human	O
type	O
1	I:C0011854
diabetes	I:C0011854
and	O
carry	O
important	O
implications	O
for	O
targeting	O
Tfh	B:C0018894
cells	I:C0018894
and	O
/	O
or	O
B	O
cells	I:C0004561
therapeutically	O
.	O

These	O
findings	O
suggest	O
a	O
role	O
for	O
Tfh	O
cells	I:C0018894
in	O
the	O
pathogenesis	O
of	O
human	O
type	O
1	I:C0011854
diabetes	I:C0011854
and	O
carry	O
important	O
implications	O
for	O
targeting	O
Tfh	O
cells	I:C0018894
and	O
/	O
or	O
B	B:C0004561
cells	I:C0004561
therapeutically	O
.	O

These	O
findings	O
suggest	O
a	O
role	O
for	O
Tfh	O
cells	I:C0018894
in	O
the	O
pathogenesis	O
of	O
human	O
type	O
1	I:C0011854
diabetes	I:C0011854
and	O
carry	O
important	O
implications	O
for	O
targeting	O
Tfh	O
cells	I:C0018894
and	O
/	O
or	O
B	O
cells	I:C0004561
therapeutically	B:C0087111
.	O

